THOR Integrated Device With a unique world-first ability to perform laser atherectomy and laser-based intravascular ...

Cardiovascular disease, sometimes abbreviated as CVD, is the leading cause of death worldwide. It’s a catchall term for heart ...

Diabetes silently affects millions globally, often progressing without obvious symptoms until it creates life-altering complications. Among the most s ...

Interventional cardiologist Dr. Ross Melvin joins us to give a demonstration of the new technology available to treat peripheral arterial disease.

Diabetic Ulcers are a serious complication that can lead to serious complications for those that suffer from them, but there ...

Abbott has delivered new, longer-term data from a clinical study of its dissolving stent for severe peripheral artery disease ...

Netherlands-based diagnostics imaging company Royal Philips announced the enrolment of its first patient in the US THRO IDE ...

In an analysis of more than 7,000 stroke survivors, those who were taking either a GLP1-receptor agonist or an SGLT2 ...

The company has announced that its new investigational device exemption will be used to launch a pivotal trial of its treatment for peripheral arterial disease.

With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery ...

Abbott announces positive data from LIFE-BTK trial of Esprit BTK System in people with peripheral artery disease below the knee: Las Vegas Wednesday, November 6, 2024, 14:00 Hrs [ ...